Yazan Abou-Ismail: Pleasure Discussing Factor 11 Inhibitors with Nashwa Abdulsalam at Heart Rhythm TV
Yazan Abou-Ismail, Associate Professor of Hematology at the University of Utah, shared Heart Rhythm TV’s post on LinkedIn:
“Pleasure discussing factor 11 inhibitors with Nashwa Abdulsalam at Heart Rhythm TV.
There is always a lot of multidisciplinary overlap between hematology and cardiology.
(We recorded this prior to the recent FDA approval, it’s great to see that asundexian has since been approved for non-cardioembolic stroke!)”
Heart Rhythm TV shared a post on LinkedIn:
“Can we prevent stroke without increasing bleeding?
Factor XI inhibitors aim to ‘uncouple’ thrombosis from hemostasis.
But AF trial results have been mixed so far.
Nashwa Abdulsalam and hematologist Yazan Abou-Ismail, M.D., unpack the science and the data.
Watch the full conversation on HRStvs’s Youtube channel.”
Stay updated with Hemostasis Today.
-
Nov 12, 2026, 11:57Javed Anees: Asundexian – A New Era in Secondary Stroke Prevention
-
Nov 12, 2026, 10:30Nancy Di Salvo: Protecting Access to IVIG and SCIG – A Call for Continued EU Recognition
-
Nov 12, 2026, 10:28Ali Hammed: Should DOAC Use Exclude Patients From Thrombolysis After Ischemic Stroke?
-
Nov 12, 2026, 10:21Aseem Kumar Tiwari: The Molecular Dimension of HLA Matching
-
Nov 12, 2026, 10:18Sarah Connolly: Developing Advanced Haematology Services in Cancer Care
-
Nov 12, 2026, 10:13Carlos Esteban Gasko: Restrictive Transfusion in Critical Care
-
Nov 12, 2026, 10:07Samin Mohsenian: Advancing Care in Rare Bleeding Disorders
-
Nov 12, 2026, 10:03Influenza Vaccination in Patients With ITP – ITP Support Association
-
Nov 12, 2026, 10:00Akshat Jain: Asundexian for Recurrent Stroke Prevention